Diabetes Channel
Topics
Medications
Quicklinks
Related Channels

NovoLog Drug Interactions

When certain medications are taken in combination with NovoLog, drug interactions could occur. While some interactions can increase blood sugar levels (which is not immediately dangerous), others can lead to low blood sugar (which can be extremely dangerous). Some of the medications that may cause potentially life-threatening NovoLog interactions include fibrate cholesterol medications, sulfonamide antibiotics, beta blockers, and oral diabetes medicines.

NovoLog Drug Interactions: An Overview

NovoLog® (insulin aspart) can potentially interact with numerous medications, too many to list entirely in this article. Some interactions (which are not discussed in this article) may increase blood sugar levels, which is not healthy but is usually not dangerous right away. Other NovoLog drug interactions can result in dangerously low blood sugar levels (hypoglycemia), which can be life-threatening. Some of the medicines that may cause dangerously low blood sugar when combined with NovoLog include:
 
  • Angiotensin-converting enzyme inhibitors (ACE inhibitors), such as:

 

 

 

 

 

 

  • Monoamine oxidase inhibitors (MAOIs), such as:

 

 

 

    • Aspirin (Ecotrin®, Bayer®, Anacin®)
    • Choline magnesium trisalicylate (Trilisate®)
    • Diflunisal (Dolobid®)
    • Salsalate (Salflex®, Disalcid®, Amigesic®)

 

  • Sulfonamide antibiotics ("sulfa drugs"), such as:

 

    • Sulfadiazine
    • Sulfadoxine (Fansidar®)
    • Sulfamethoxazole (Bactrim®, Septra®)
    • Sulfisoxazole (Gantrisin®)
 

 

Steps to Prevent or Delay Diabetic Nerve Damage

NovoLog Insulin

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.